Fund profile

Navy Capital

New York, United States

Not leading

About

Navy Capital is a New York-based hedge fund founded in 2014, with a strong focus on the rapidly expanding global cannabis industry. The fund operates through a research-driven, long/short equity strategy, leveraging deep analysis to identify undervalued opportunities primarily within the legal cannabis, cannabis healthtech, and crop tech sectors. Their investment portfolio includes notable startups like Sanity Group, Harborside, and C3 Industries, making Navy Capital a significant player in the cannabis and consumer non-durables spaces. Geographically, Navy Capital concentrates investments predominantly in the U.S., while also backing ventures in Germany and other regions. The fund's average check size typically targets early to mid-stage companies, often participating in Series A and B rounds. However, they remain flexible in their approach, willing to lead or co-invest alongside other firms depending on the opportunity. The team is led by Sean Stiefel, CEO and Founder, and supported by key players like Chetan Gulati, Head of Research. With a background in hedge fund management and macro strategy, the team boasts a combined experience across finance, law, and global equity markets. Navy Capital's proactive approach to investing, combined with a willingness to engage deeply with portfolio companies, helps build strong relationships with founders. Startups looking to connect are encouraged to demonstrate solid fundamentals and long-term growth potential, particularly in regulated industries like cannabis, where Navy Capital thrives.

Details

Average check

$3M-$10M$10M-$50M

Round

SeedSeries BSeries A

Highlights

$13.3M

Historical average check

$44.2M

Historical max check

July 2021

Last investment date

14

Investments

Cannabis & Psychedelics

Healthtech & Wellness

E-commerce & Retail

Hardware. Robotics & IoT

Other

Funds that also invest in Cannabis & Psychedelics